Potential treatment for hay fever and asthma identifiedA potential drug has been identified and about to undergo trials in humans for treating hay fever and asthma.

The drug, RPL554, apparently has the ability to effectively treat respiratory diseases and does not lead to side effects that are usually common characteristics of many of the currently used medications.

It was remarked by Dr. Clive Page, chairman of Verona Pharma, which is developing the treatment, that his company is also ascertaining other novel compounds to tackle respiratory diseases on the lines of anti-inflammatory substances found in starfish and a treatment for coughs.